Stem Cell Therapy for Shoulders: Rotator Cuff, Arthritis, and What the Research Shows
Explore the clinic directoryIn this article
Stem cell treatment for a shoulder labral tear usually means an ultrasound-guided injection of your own bone marrow aspirate concentrate (BMAC) or fat-derived cells into the torn labrum and joint, but published evidence for labral tears is limited to small case series, with no randomized controlled trials. The strongest shoulder data is for rotator cuff tears and mild to moderate glenohumeral arthritis, and every one of these uses remains cash pay and outside FDA approval.
Key Takeaways
- For shoulder labral tears, including SLAP tears, stem cell injections are supported only by case reports and small series; no randomized trial has tested them in the shoulder labrum.
- In a randomized crossover trial, Centeno and colleagues (2024, BMC Musculoskeletal Disorders) found that bone marrow concentrate plus platelet products improved pain and function more than home exercise for high-grade partial and full-thickness supraspinatus tears over 2 years.
- When surgeons added bone marrow stem cells to arthroscopic rotator cuff repair, Hernigou and colleagues (2014, International Orthopaedics) reported intact repairs at 10 years in 87% of treated patients versus 44% of matched controls.
- For shoulder osteoarthritis, a 2015 registry of 115 shoulders treated with bone marrow concentrate (Centeno, Journal of Pain Research) showed average disability scores improving from 36.1 to 17.1, without a control group.
- According to the FDA, no stem cell product is approved for orthopedic shoulder conditions, and insurers generally classify these injections as investigational, so patients pay out of pocket.
At a Glance
- Common shoulder conditions treated: Rotator cuff tears (partial), labral tears, glenohumeral arthritis, frozen shoulder
- Cell sources: Bone marrow concentrate (BMAC), adipose-derived stem cells, or umbilical cord tissue
- Procedure time: 1-2 hours including cell harvest and injection
- Recovery: Sling for 1-2 weeks, gradual return to activity over 6-12 weeks
- Cost: $3,000-8,000+ depending on cell source and provider
Why the Shoulder Is a Prime Target for Regenerative Treatment
The shoulder is the most mobile joint in the body, and that mobility comes at a cost. The rotator cuff, labrum, and surrounding structures are under constant stress, making them vulnerable to degeneration and injury.
Traditional options for chronic shoulder problems range from physical therapy (which has limits for structural damage) to cortisone injections (which provide temporary relief but may weaken tissue over time) to surgery (which carries significant downtime and its own failure rates).
Stem cell therapy sits between conservative care and surgical intervention. It aims to reduce inflammation, promote tissue repair, and potentially regenerate damaged cartilage and tendon tissue. This approach is gaining traction as research accumulates, though the evidence varies by condition. For a full look at stem cell treatments, see our stem cell therapy guide.
The cells most clinics use are mesenchymal stem cells (MSCs), also called mesenchymal stromal cells or medicinal signaling cells. They are harvested from your own bone marrow or fat (autologous) or taken from donated birth tissue (allogeneic). The stem cell therapy treatment guide explains each source, and our explainer on how mesenchymal stem cells work covers the biology in more depth.
Shoulder Conditions Treated with Stem Cells
Partial Rotator Cuff Tears
Partial-thickness rotator cuff tears are among the most promising applications for stem cell therapy in the shoulder. These tears involve damage to one or more of the four rotator cuff tendons (supraspinatus, infraspinatus, subscapularis, teres minor) without a complete disruption. When a partial tear is left untreated, it can progress to a full-thickness tear over time.
The best controlled data comes from a randomized crossover trial by Centeno and colleagues (2024, BMC Musculoskeletal Disorders). Fifty-one patients with high-grade partial or full-thickness supraspinatus tears received either percutaneous bone marrow concentrate with platelet products or a home exercise program. The injection group reported significantly greater improvement in pain, DASH disability scores, and overall shoulder rating through 2 years of follow-up.
Stem cells may help partial tears by reducing the inflammatory environment within the tendon, stimulating tenocyte (tendon cell) proliferation, and promoting organized collagen deposition rather than scar tissue formation.
Labral Tears
The labrum is a ring of cartilage that deepens the shoulder socket and helps stabilize the humeral head. Labral tears, including SLAP tears (Superior Labrum Anterior to Posterior), often result from overhead sports, falls, or repetitive strain.
Research on stem cells for labral tears is more limited than for rotator cuff pathology. Small case series have shown improved pain and function scores after stem cell injection, but high-quality RCTs are still lacking. The labrum has poor blood supply, which makes natural healing difficult. Stem cells may provide growth factors and signaling molecules that partially compensate for this limited vascularity. The dedicated labral tear section below covers candidates, technique, and alternatives.
Glenohumeral Arthritis
Arthritis of the shoulder joint (glenohumeral osteoarthritis) involves progressive cartilage loss, bone spur formation, and chronic inflammation. While stem cell therapy cannot regrow a fully eroded joint surface, it may slow progression, reduce pain, and improve function in mild to moderate cases.
Studies of mesenchymal stem cell therapy for shoulder OA report fairly consistent pain reduction and functional improvement, though sample sizes are small and follow-up periods vary. Patients with bone-on-bone arthritis (Kellgren-Lawrence Grade IV) typically see less benefit than those with mild to moderate disease. Readers comparing options for osteoarthritis in other joints will find the same pattern.
Frozen Shoulder (Adhesive Capsulitis)
Frozen shoulder involves inflammation and fibrosis of the joint capsule, leading to progressive stiffness and pain. While it is typically self-limiting (resolving over 1-3 years), the prolonged disability is significant.
Some providers use stem cell or PRP injections during the “freezing” or “frozen” phase to modulate inflammation and potentially shorten the disease course. Evidence is preliminary, and standard care with physical therapy, corticosteroid injection, or hydrodilatation has a much larger research base.
Stem Cell Treatment for Shoulder Labral Tears
Stem cell treatment for a shoulder labral tear is an injection of concentrated cells, most often bone marrow aspirate concentrate, placed into the glenohumeral joint next to the torn labrum under ultrasound or fluoroscopic guidance. The goal is to calm inflammation and support healing in tissue with a poor blood supply. It is an off-label, cash-pay procedure, and the research behind it is thinner than for any other shoulder use on this page.
What does the research show for labral tears?
No randomized controlled trial has tested stem cell injections for tears of the shoulder labrum. The published record consists of case reports and small case series, which cannot separate the effect of the cells from rest, physical therapy, and natural recovery. Most bone marrow concentrate research on the labrum comes from the hip, where it is used to augment surgical repair, and those results cannot be assumed to carry over to the shoulder.
Which labral tears are considered for injection?
Clinicians who offer this treatment usually reserve it for degenerative or fraying tears and stable SLAP tears in patients whose main problem is pain rather than repeated dislocation. A Bankart tear, where the front of the labrum pulls away after a shoulder dislocation, causes mechanical instability. An injection cannot reattach detached tissue, so recurrent instability is generally treated with arthroscopic repair by an orthopedic surgeon.
How does it compare with the standard options?
First-line care for a painful labral tear is physical therapy focused on rotator cuff and scapular strength, often with a corticosteroid injection. Arthroscopic repair, biceps tenodesis, or debridement follow when symptoms persist. Some sports medicine physicians try PRP injection for the shoulder before bone marrow concentrate because it is less invasive and better studied for shoulder tendons.
Bone Marrow Stem Cell Therapy for Shoulder Arthritis
Bone marrow stem cell therapy for shoulder arthritis uses BMAC, drawn from the back of the hip bone and concentrated in a centrifuge, injected into the glenohumeral joint to reduce pain and inflammation. Studies show the clearest gains in mild to moderate osteoarthritis. Joints with bone-on-bone wear rarely improve enough to avoid shoulder replacement.
The largest shoulder-specific dataset is a registry of 115 shoulders in 102 patients with glenohumeral osteoarthritis or rotator cuff tears, published by Centeno and colleagues (2015, Journal of Pain Research). Average DASH disability scores improved from 36.1 to 17.1 after bone marrow concentrate injection. The authors called the results preliminary because the study had no control group and described it as a basis for a randomized trial.
Who is a reasonable candidate?
Physicians in physical medicine and rehabilitation, sports medicine, and orthopedics tend to consider BMAC for patients with Kellgren-Lawrence grade II or III changes who have not responded to exercise therapy, activity changes, and cortisone or hyaluronic acid injections. People with advanced joint collapse, inflammatory arthritis that is not controlled, or active infection are poor candidates. A broader view of osteoarthritis treatment options helps put this in context.
PRP vs. Stem Cells for Shoulder Conditions
PRP (platelet-rich plasma) and stem cells are both regenerative treatments, but they work through different mechanisms and carry different price tags. Understanding the distinction helps you and your provider choose the right approach. For a detailed comparison, see our PRP vs. stem cell therapy guide.
| Factor | PRP | Stem Cell Therapy (BMAC) |
|---|---|---|
| What it contains | Concentrated platelets, growth factors | Mesenchymal stem cells, growth factors, platelets |
| Source | Patient’s blood (simple blood draw) | Bone marrow (iliac crest aspiration) or adipose tissue |
| Mechanism | Growth factor signaling, inflammation modulation | Cell differentiation, paracrine signaling, immunomodulation |
| Best for | Tendinopathy, mild arthritis, early-stage injuries | Moderate arthritis, partial tears, more significant tissue damage |
| Cost | $500-1,500 per injection | $3,000-8,000+ |
| Evidence strength | Moderate (more RCTs available) | Growing (fewer but promising RCTs) |
Many regenerative medicine practices use a stepwise approach: start with PRP for milder pathology, and reserve stem cell therapy for cases where PRP was insufficient or the degree of tissue damage warrants a stronger biological intervention. The platelet-rich plasma treatment guide describes how PRP is prepared and graded.
The Procedure: What Actually Happens
Cell Harvest
For bone marrow-derived stem cells (BMAC), the provider performs a bone marrow aspiration, usually from the posterior iliac crest (the back of the hip bone). This is done under local anesthesia and takes about 15-20 minutes. Most patients describe it as pressure with mild discomfort, not sharp pain. The aspirate is then centrifuged to concentrate the stem cells and growth factors.
For adipose-derived stem cells, a small liposuction procedure harvests fat tissue, typically from the abdomen or flanks. The fat is then processed to isolate the stromal vascular fraction (SVF) containing stem cells.
The Injection
The concentrated cells are injected into the shoulder using ultrasound or fluoroscopic guidance. Image guidance is critical for accurate placement, as the shoulder has complex anatomy with small target structures. The injection itself takes just a few minutes.
Some providers combine PRP with stem cells in the same injection, using the platelet-rich plasma as a “scaffold” and additional source of growth factors.
Studies show that blind (non-guided) shoulder injections miss their target up to 45% of the time. Ultrasound-guided injections achieve accurate placement in over 95% of cases. Always confirm that your provider uses real-time imaging for shoulder injections.
Recovery Timeline
Recovery from stem cell injection is significantly faster than surgical alternatives, but it is not instant. The cells need time to engraft and begin their work.
Days 1-3: Mild to moderate soreness at the injection site and the bone marrow harvest site (if BMAC was used). Ice and acetaminophen for comfort. Avoid NSAIDs, as they can interfere with the inflammatory signaling that stem cells need to function.
Weeks 1-2: Sling use recommended for comfort and to protect the injection site. Gentle range-of-motion exercises as tolerated. No lifting above 5 pounds.
Weeks 3-6: Progressive physical therapy begins. Gradual increase in range of motion and light strengthening. Many patients notice the beginning of pain improvement during this phase.
Weeks 6-12: Continued therapy progression. Return to most daily activities. Avoid heavy lifting or overhead sports until cleared by your provider.
Months 3-6: Maximum benefit typically occurs during this window. Follow-up imaging (MRI or ultrasound) may be performed to assess structural changes.
Non-steroidal anti-inflammatory drugs (ibuprofen, naproxen, aspirin) should be avoided for at least 2-4 weeks after stem cell injection. These medications suppress the inflammatory cascade that stem cells rely on for signaling and engraftment. Use acetaminophen (Tylenol) for pain management instead.
What the Research Actually Shows
The evidence for stem cell therapy in shoulder conditions is promising but still maturing. Here is an honest assessment by condition:
Partial rotator cuff tears: The strongest shoulder-specific evidence. Prospective studies and at least one randomized trial show improved pain and function at 1-2 year follow-up. In the Centeno (2024) crossover trial, bone marrow concentrate with platelet products outperformed home exercise on pain, DASH, and SANE scores for high-grade partial and full-thickness supraspinatus tears at 2 years.
Shoulder osteoarthritis: Moderate evidence. Most studies show pain improvement and functional gains, but cartilage regeneration on imaging is inconsistent. Stem cells appear to work more through anti-inflammatory and paracrine effects than through true cartilage regrowth in most cases.
Full-thickness rotator cuff tears: Limited evidence as a standalone treatment. Some studies use stem cells as an adjunct to surgical repair (augmenting the healing of the surgical repair), with promising results for improved healing rates and reduced re-tear rates. In a case-controlled study by Hernigou and colleagues (2014, International Orthopaedics), all 45 repairs augmented with bone marrow concentrate had healed by 6 months, compared with 30 of 45 controls, and 87% versus 44% remained intact at 10 years.
Labral tears: Early-stage evidence. Case reports and small series suggest benefit, but no RCTs exist. This remains an area where clinical experience outpaces published data.
| Shoulder condition | Best available evidence | Typical role of stem cells |
|---|---|---|
| Partial rotator cuff tear | Randomized crossover trial and prospective studies | Nonsurgical injection after failed physical therapy |
| Full-thickness rotator cuff tear | Case-controlled surgical study with 10-year follow-up | Add-on during arthroscopic repair |
| Glenohumeral osteoarthritis | Registry data without a control group | Pain relief in mild to moderate disease |
| Labral tear, including SLAP | Case reports and small case series | Off-label option for stable, painful tears |
| Frozen shoulder | Preliminary reports only | Experimental, alongside standard care |
Regulation, Insurance, and How to Choose a Clinic
The U.S. Food and Drug Administration has not approved any stem cell product for rotator cuff tears, labral tears, or shoulder arthritis. The agency’s consumer information on regenerative medicine therapies warns patients about clinics marketing unapproved stem cell products and encourages them to ask whether a treatment is being studied under an FDA investigational application.
Because insurers treat these injections as investigational, most patients pay the full fee themselves. Our breakdown of what stem cell therapy costs explains what is usually included, and the FDA status of stem cell treatments is covered in a separate post.
To compare providers, the national directory of stem cell therapy clinics lets you filter by state and city and read each profile. Regenerated.com is free for patients, listing order is not paid ranking, Featured slots are labeled and capped, and Verified means a clinic passed credential checks, not that it spent money. The guide to Featured, Verified, and organic listings explains each label, and inclusion in the directory is not an endorsement.
Frequently Asked Questions
Is stem cell therapy for the shoulder FDA-approved?
No. No stem cell product is FDA-approved for rotator cuff tears, labral tears, or shoulder arthritis. Autologous procedures using your own bone marrow or fat are performed under the practice of medicine, and the FDA generally does not require premarket approval when cells are only minimally manipulated and used for a similar function in the body. Products that are cultured, expanded, or sourced from donors fall under stricter drug rules and need FDA approval or an investigational application.
How many injections will I need?
Most shoulder protocols use a single stem cell injection, sometimes paired with PRP injections before or after it. If improvement is only partial after about 6 months, some physicians consider a second stem cell injection. The need for repeat treatment depends on the type and severity of the tear or arthritis, the patient’s age and health, and the individual healing response, so a clinic should explain its reasoning before recommending more than one.
Can stem cells help me avoid shoulder surgery?
In some cases, yes. The strongest data supports avoiding surgery for partial rotator cuff tears and mild to moderate arthritis, where controlled and registry studies report better pain and function than before treatment. For large full-thickness rotator cuff tears, massive tears, labral tears causing repeated dislocation, or severe bone-on-bone arthritis that needs shoulder replacement, stem cell therapy is unlikely to replace surgery and is better discussed as an add-on.
Does insurance cover stem cell injections for the shoulder?
In most cases, no. The vast majority of private insurance plans and Medicare consider stem cell therapy experimental or investigational for orthopedic conditions, including the shoulder. Patients typically pay out of pocket for the cell harvest, processing, image-guided injection, and follow-up visits. Some providers offer payment plans, and a health savings account may help, so ask for a written, itemized quote before booking.
What is the difference between “stem cells” from birth tissue products and my own bone marrow?
Products marketed as “stem cells” from amniotic fluid, umbilical cord tissue, or placental tissue often contain growth factors and extracellular matrix components but very few, if any, viable stem cells. Studies have shown that most commercially available birth tissue products do not contain living stem cells after processing and storage. Autologous bone marrow concentrate contains your own living mesenchymal stem cells and has a stronger evidence base for shoulder use.
How do I find a qualified provider?
Look for a physician board-certified in sports medicine, orthopedic surgery, or physical medicine and rehabilitation who uses ultrasound or fluoroscopy for every injection, processes cells in-house, and can discuss the evidence honestly, including its limits. Ask how many shoulder procedures they perform and what they do if results fall short. Be cautious of providers who promise results or use aggressive marketing, and use a clinic directory to compare credentials.
